J Gelzer
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 4
- Microbiology top 10%
-
- Antimicrobial agents and applications 5
-
- Antibiotics Pharmacokinetics and Efficacy 6
-
- Cancer, Hypoxia, and Metabolism 3
-
- Vector-borne infectious diseases 3
-
- Pharmaceutical and Antibiotic Environmental Impacts 3
-
- Environmental Chemistry and Analysis 3
-
- Influenza Virus Research Studies 2
J Gelzer
40 papers receiving 404 citations
Peers
Comparison fields: 5 of 98
- Molecular Medicine 60
- Endocrinology 30
- Microbiology 36
- Applied Microbiology and Biotechnology 9
- Organic Chemistry 126
Countries citing papers authored by J Gelzer
This map shows the geographic impact of J Gelzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Gelzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Gelzer more than expected).
Fields of papers citing papers by J Gelzer
This network shows the impact of papers produced by J Gelzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Gelzer. The network helps show where J Gelzer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J Gelzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 6 | |
| 2 | Verbreitung von Coxiella burnetii: eine seroepidemiologische Untersuchung bei Haustieren und Tierarzten | 1983 | 8 |
| 3 | Resistenzhäufigkeit von Escherichia coli in der Schweiz | 1981 | 1 |
| 4 | [Frequency of Escherichia coli resistance in Switzerland]. | 1981 | 1 |
| 5 | 1979 | 4 | |
| 6 | 1978 | 1 | |
| 7 | 1976 | 4 | |
| 8 | Antimicrobial studies in vitro with cephacetrile, a new cephalosporin derivative. | 1974 | 3 |
| 9 | 1971 | 39 | |
| 10 | 1971 | 33 | |
| 11 | Antimicrobial studies in vitro with CIBA 36278-Ba, a new cephalosporin derivative. | 1970 | 19 |
| 12 | 1970 | 14 | |
| 13 | 1970 | 1 | |
| 14 | Chemotherapeutic activity of rifampin against gram-negative bacteria with reference to urinary-tract infection in rats. | 1968 | 5 |
| 15 | 1968 | 9 | |
| 16 | 1967 | 10 | |
| 17 | On the specificity of the antitumor action 4,4'-diacetyl-diphenyl- -urea-bis-guanylhydrazone on rodent tumors. Abstr. | 1967 | 2 |
| 18 | 1964 | 22 | |
| 19 | 1959 | 25 | |
| 20 | [Cancer of seminal vesicles 14 years after contrast demonstration of urinary fistula with thorotrast]. | 1959 | 7 |
About J Gelzer
J Gelzer is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Parasitology and Pharmacology, having authored 41 papers that have together received 488 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antimicrobial agents and applications (5 papers), Antibiotic Resistance in Bacteria (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Vector-borne infectious diseases (3 papers), Pharmaceutical and Antibiotic Environmental Impacts (3 papers), Environmental Chemistry and Analysis (3 papers) and Influenza Virus Research Studies (2 papers). The work is most often cited by research in Molecular Medicine (60 citations), Endocrinology (30 citations), Microbiology (36 citations), Applied Microbiology and Biotechnology (9 citations) and Organic Chemistry (126 citations). J Gelzer has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Frank W. Adair, Elvin A. Kabat, P. Loustalot, Emanuel Suter, R. Hess, F.M. Dietrich, F. Knüsel, A. Rosselet, Enrico Mihich and R. Bruppacher. Their work appears in journals such as The Journal of Experimental Medicine, The Lancet, International Journal of Cancer, Cellular and Molecular Life Sciences and The Journal of Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.